½ÃÀ庸°í¼­
»óǰÄÚµå
1404767

ÇϹݽŠÀÇÁ· ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Lower Limb Prosthetics Market Size, Share & Trends Analysis Report By Type (Prosthetics Foot, Prosthetics Knee, Prosthetics Leg, Prosthetics Ankle), By Technology, By End-use (Hospitals, Clinics, Others), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇϹݽŠÀÇÁ· ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÇϹݽŠÀÇÁ· ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 16¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGRÀº 4.70%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´ À¯º´·ü Áõ°¡´Â »çÁö °á¼Õ Áõ°¡·Î À̾îÁ® ÀÇÁ· º¸Ã¶¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ º¸°Çº¹ÁöºÎÀÇ ÃÖ±Ù ÃßÁ¤¿¡ µû¸£¸é ÇöÀç ¹Ì±¹¿¡´Â 190¸¸ ¸íÀÇ »çÁö °á¼Õ ȯÀÚ°¡ ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, ÀÌ ¼ýÀÚ´Â ÁÖ·Î ´ç´¢º´ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2050³â±îÁö 4¹è·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Ç÷°ü Áúȯ Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ¿äÀÎÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Ç÷°ü ÁúȯÀº ÇÏÁö Àý´ÜÀÇ À§ÇèÀ» Áõ°¡½ÃÄÑ ÇϹݽŠÀÇÁ·ÀÇ Çʿ伺À» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÁúȯÀº ½ÅüÀÇ Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, ÀÌ Ç÷°üÀÌ ´Ù¸®¿Í Ç㸮¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸Æ¿¡ ¿µÇâÀ» ¹ÌÄ¡¸é ¸»Ãʵ¿¸ÆÁúȯ(PAD)À¸·Î ¾Ë·ÁÁø »óŸ¦ ÃÊ·¡ÇÕ´Ï´Ù.

»õ·Î¿î ±â¼ú°ú Àç·áÀÇ µµÀÔÀº ȯÀÚ¿¡°Ô ´õ ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¦Ç°À» ¸¸µé¾î³Â½À´Ï´Ù. ¿ì·¹Åº, ½Ç¸®ÄÜ, ¹Ì³×¶ö ±â¹Ý ¶óÀÌ³Ê µî ÀÇÁ·¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ·¯ÇÑ ½Å¼ÒÀç´Â ¸ñÀç ¹× °æÁú ÇÃ¶ó½ºÆ½°ú °°Àº ±âÁ¸ ¼ÒÀç¿¡ ºñÇØ ÈξÀ °¡º±°í À¯¿¬ÇÏ¸ç ³»±¸¼ºÀÌ ¶Ù¾î³ª°í ½Å·ÚÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀº Ç÷°üÀ̳ª ´ç´¢º´À¸·Î ÀÎÇØ ÆÈ°ú ´Ù¸®¸¦ ÀÒÀº ¼ÒºñÀÚµéÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ÇϹݽŠÀÇÁ· ½ÃÀå ¼ºÀåÀº ±â¼ú ¹ßÀü°ú ÀÌ·¯ÇÑ Àç·áÀÇ »ç¿ë Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 6¿ù ¹Ì±¹ ÀçÇⱺÀÎȸ´Â Courtney ShellÀ» »ç¿ëÇÏ¿© ½À±â¸¦ Èí¼öÇÏ¿© ÀÇÁ·ÀÇ Æí¾ÈÇÔÀ» ³ôÀ̱â À§ÇØ »õ·Î¿î ±â¼ú ÀÇÁ· ¼ÒÄÏ ¶óÀ̳ÊÀÇ Å×½ºÆ®¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

ÇÏÁö º¸Á¶±â¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀåÀÇ ÁÖ¿ä ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÇÁ·Àº Ãʱ⠱¸¸Å ºñ¿ë»Ó¸¸ ¾Æ´Ï¶ó Áö¼ÓÀûÀÎ À¯Áö º¸¼ö ºñ¿ë°ú ÀáÀçÀûÀÎ ±³Ã¼ ºñ¿ëµµ Æ÷ÇԵǴ °í°¡ÀÇ Á¦Ç°ÀÔ´Ï´Ù. ¸¹Àº »ç¶÷µé, ƯÈ÷ ÃæºÐÇÑ º¸Çè¿¡ °¡ÀÔÇÏÁö ¾Ê¾Ò°Å³ª °æÁ¦Àû ¿©À¯°¡ ¾ø´Â »ç¶÷µé¿¡°Ô´Â ¾öû³­ ºñ¿ëÀÌ ÀÌ·¯ÇÑ ÇʼöÀûÀÎ ±â±â¸¦ »ç¿ëÇÏ´Â µ¥ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ °æÁ¦Àû ¹®Á¦´Â º¸Ã¶ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» Á¦ÇÑÇϰí ȯÀÚÀÇ Ã·´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±ÙÀ» ¹æÇØÇÏ¿© ±Ã±ØÀûÀ¸·Î ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÇϹݽŠÀÇÁ· ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ½ÃÀå À¯Çüº°·Î´Â ÀÇÁ·, ÀÇÁ·, ÀÇÁ· ¹«¸­, ÀÇÁ·, ÀÇÁ· °üÀý, ÀÇÁ· °í°üÀý·Î ³ª´¹´Ï´Ù. ÀÇÁ· ºÎ¹®Àº 2023³â 30.92%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Àΰø °í°üÀý ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 5.07%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ¹è°æ¿¡´Â ¸¸¼º ÁúȯÀÇ È®»ê°ú ³ë·ÉÈ­ÀÇ ÁøÇàÀÌ ÀÖ½À´Ï´Ù.
  • ±â¼ú¿¡ µû¶ó ½ÃÀåÀº ±âÁ¸ ÇϹݽŠÀÇÁ·, Àüµ¿ ÇϹݽŠÀÇÁ·, ÇÏÀ̺긮µå ÇϹݽŠÀÇÁ·À¸·Î ³ª´¹´Ï´Ù. ±âÁ¸ ÇϹݽŠÀÇÁ· ºÐ¾ß´Â 2023³â 41.91%ÀÇ °¡Àå Å« ½ÃÀå ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹Ý¸é, Àüµ¿ ÇϹݽŠÀÇÁ· ºÐ¾ß´Â ÀÇÁ· º¸Á¶±â ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È 4.89%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº º´¿ø, Ŭ¸®´Ð, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Ŭ¸®´Ð ºÎ¹®Àº 2023³â 53.98%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 4.81%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2023³â¿¡´Â ºÏ¹Ì°¡ 45.75%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó, ´ç´¢º´ÀÇ À¯Çà¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÌ Áö¿ªÀÇ ÇϹݽŠÀÇÁ· ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇâÈÄ ¸î ³âµ¿¾È °¡Àå ºü¸¥ CAGR 7.33%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇϹݽŠÀÇÁö ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • º¸±Þ ¹× ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
    • »óȯ ÇÁ·¹ÀÓ¿öÅ©
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ÇϹݽŠÀÇÁö ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ÇϹݽŠÀÇÁö ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÇϹݽŠÀÇÁö ½ÃÀå, À¯Çüº° Áß¿ä Æ÷ÀÎÆ®
  • ÇϹݽŠÀÇÁö ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • Á¾¾Æ¸® ÀÇÁ·
  • ¹«¸­ ÀÇÁ·
  • ´ëÅð ÀÇÁ·
  • ¹ß¸ñ ÀÇÁ·
  • °¡¶ûÀÌ ÀÇÁ·

Á¦5Àå ÇϹݽŠÀÇÁö ½ÃÀå : ±â¼ú ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÇϹݽŠÀÇÁö ½ÃÀå, ±â¼úº° Áß¿ä Æ÷ÀÎÆ®
  • ÇϹݽŠÀÇÁö ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ±âÁ¸ ÇϹݽŠÀÇÁö
  • Àüµ¿ ÇϹݽŠÀÇÁö
  • ÇÏÀ̺긮µå ÇϹݽŠÀÇÁö
  • ±âŸ

Á¦6Àå ÇϹݽŠÀÇÁö ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÇϹݽŠÀÇÁö ½ÃÀå, ÃÖÁ¾ ¿ëµµº° Áß¿ä Æ÷ÀÎÆ®
  • ÇϹݽŠÀÇÁö ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • º´¿ø
  • Ŭ¸®´Ð
  • ±âŸ

Á¦7Àå ÇϹݽŠÀÇÁö ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° Àü¸Á
  • Áö¿ªº° ÇϹݽŠÀÇÁö ½ÃÀå : ¸¶ÄÏÇ÷¹À̽º Áß¿ä Æ÷ÀÎÆ®
  • ºÏ¹Ì
    • SWOT ºÐ¼®
    • ºÏ¹Ì ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • SWOT ºÐ¼®
    • À¯·´ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • SWOT ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ű¹
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • SWOT ºÐ¼®
    • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • SWOT ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ȸ»ç/°æÀï»ç ºÐ·ù
    • Enovis
    • Fillauer
    • Ossur(Touch Bionics)
    • Ottobock SE
    • Endolite
    • College Park Industries
    • Steeper Group
    • TRS Inc
    • Naked Prosthetics
    • DePuy Synthes
LSH 24.01.23

Lower Limb Prosthetics Market Growth And Trends

The global lower limb prosthetics market size is expected to reach a value of USD 1.63 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.70%. The rising prevalence of diabetes leads to an increasing number of limb loss which in turn drives demand for limb prosthetics. According to recent estimates by the U.S. Department of Health and Human Services, there are currently 1.9 million estimated limb-loss sufferers in the U.S. and this number is projected to quadruple by 2050, primarily as a result of increased incidence of diabetes. In addition, the increasing number of vascular diseases can also be a significant factor for market growth. Vascular diseases can increase the risk of lower limb amputations and, subsequently, the need for lower limb prostheses. This disease affects blood vessels in the body, and when these blood vessels affect arteries that supply blood to the legs and feet, it can lead to a condition known as peripheral arterial disease (PAD).

The introduction of new technology and materials has led to the creation of reliable products for patients. Compared to traditional materials such as wood and hard plastics, these new materials found in prosthetic devices including urethane, silicone, and mineral-based liners are far more lightweight, flexible, durable, and reliable. Such characteristics attract consumers who lose their arm or leg due to vascular and diabetes conditions. The market growth for lower prosthetic limbs is being driven by developments in technology and increased use of these materials. For instance, in June 2020, the U.S. Department of Veterans Affairs announced the testing of a new technology prosthetic socket liner with Courtney Shell which intends to absorb moisture and increase comfort with prostheses.

The high cost associated with lower limb prosthetics serves as a significant restraint on the market. These devices are expensive, encompassing not only the initial purchase but also ongoing maintenance and potential replacement costs. For many individuals, especially those without adequate insurance coverage or financial resources, the prohibitive cost creates a substantial barrier to accessing these essential devices. Thus, affordability issues can limit the adoption of prosthetic solutions, hinder patient access to advanced technologies, and ultimately impede market growth.

Lower Limb Prosthetics Market Report Highlights:

  • Based on type, the market is segmented into prosthetic foot, prosthetic knee, prosthetic leg, prosthetic ankle, and prosthetic hip. The prosthetic leg segment held the largest market share of 30.92% in 2023. The prosthetic hip segment is expected to grow at the fastest CAGR of 5.07% over the forecast period. This is attributed to the growing prevalence of chronic diseases and the aging population
  • Based on technology, the market is segmented into conventional lower extremity prosthetics, electric-powered lower extremity prosthetics, and hybrid lower extremity prosthetics. The conventional lower extremity prosthetics segment held the largest market revenue share of 41.91% in 2023. On the other hand, the electric-powered lower extremity prosthetics segment is expected to grow at the fastest CAGR of 4.89% over the forecast period, owing to the technological advancement in the field of prosthetics
  • Based on end use, the market is segmented into hospitals, clinics, and others. The clinics segment held the largest market share of 53.98% in 2023. This hospital segment is expected to grow at a significant CAGR of 4.81% over the forecast period
  • In 2023, North America dominated the market with a share of 45.75%, owing to the presence of major market players, well-established healthcare infrastructure and prevalence of diabetes. These factors are anticipated to boost the market for lower limb prosthetics in the region over the forecast period. Asia Pacific is expected to grow at the fastest CAGR of 7.33% in the coming years

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Lower Limb Prosthetics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Lower Limb Prosthetics Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Lower Limb Prosthetics Market: Type Estimates & Trend Analysis

  • 4.1. Lower Limb Prosthetics Market, By Type Key Takeaways
  • 4.2. Lower Limb Prosthetics Market: Movement & Market Share Analysis, 2023 & 2030
  • 4.3. Prosthetics Foot
    • 4.3.1. Prosthetics foot market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Prosthetics Knee
    • 4.4.1. Prosthetics knee market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Prosthetics Leg
    • 4.5.1. Prosthetics leg market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Prosthetics Ankle
    • 4.6.1. Prosthetics ankle market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Prosthetics Hip
    • 4.7.1. Prosthetics hip market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Lower Limb Prosthetics Market: Technology Estimates & Trend Analysis

  • 5.1. Lower Limb Prosthetics Market, By Technology Key Takeaways
  • 5.2. Lower Limb Prosthetics Market: Movement & Market Share Analysis, 2023 & 2030
  • 5.3. Conventional Lower Extremity Prosthetics
    • 5.3.1. Conventional lower extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Electric Powered Lower Extremity Prosthetics
    • 5.4.1. Electric powered lower extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Hybrid Lower Extremity Prosthetics
    • 5.5.1. Hybrid lower extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Lower Limb Prosthetics Market: End Use Estimates & Trend Analysis

  • 6.1. Lower Limb Prosthetics Market, By End Use Key Takeaways
  • 6.2. Lower Limb Prosthetics Market: Movement & Market Share Analysis, 2023 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Lower Limb Prosthetics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Lower Limb Prosthetics Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. SWOT Analysis
    • 7.3.2. North America Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. U.S.
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. U.S. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.4. Canada
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Canada Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. SWOT Analysis
    • 7.4.2. Europe Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. U.K.
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. UK Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Germany
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Germany Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. France
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. France Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Italy
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Italy Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Spain
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Spain Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.9. Sweden
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Sweden Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.10. Norway
      • 7.4.10.1. Key Country Dynamics
      • 7.4.10.2. Competitive Scenario
      • 7.4.10.3. Norway Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.11. Denmark
      • 7.4.11.1. Key Country Dynamics
      • 7.4.11.2. Competitive Scenario
      • 7.4.11.3. Denmark Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. SWOT Analysis
    • 7.5.2. Asia Pacific Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Japan Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. China
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. China Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. India
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. India Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Australia Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Thailand Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.8. South Korea
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. South Korea Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. SWOT Analysis
    • 7.6.2. Latin America Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Brazil
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Brazil Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Mexico Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.5. Argentina
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Argentina Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. SWOT Analysis
    • 7.7.2. MEA Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Saudi Arabia Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. South Africa
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. South Africa Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.5. UAE
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. UAE Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.6. Kuwait
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Kuwait Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Enovis
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Type benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Fillauer
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Type benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Ossur (Touch Bionics)
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Type benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Ottobock SE
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Type benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Endolite
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Type benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. College Park Industries
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Type benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Steeper Group
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Type benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. TRS Inc
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Type benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Naked Prosthetics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Type benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. DePuy Synthes
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Type benchmarking
      • 8.2.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦